Literature DB >> 32920142

Structure-activity relationships of GPX4 inhibitor warheads.

John K Eaton1, Laura Furst2, Luke L Cai2, Vasanthi S Viswanathan3, Stuart L Schreiber4.   

Abstract

Direct inhibition of GPX4 requires covalent modification of the active-site selenocysteine. While phenotypic screening has revealed that activated alkyl chlorides and masked nitrile oxides can inhibit GPX4 covalently, a systematic assessment of potential electrophilic warheads with the capacity to inhibit cellular GPX4 has been lacking. Here, we survey more than 25 electrophilic warheads across several distinct GPX4-targeting scaffolds. We find that electrophiles with attenuated reactivity compared to chloroacetamides are unable to inhibit GPX4 despite the expected nucleophilicity of the selenocysteine residue. However, highly reactive propiolamides we uncover in this study can substitute for chloroacetamide and nitroisoxazole warheads in GPX4 inhibitors. Our observations suggest that electrophile masking strategies, including those we describe for propiolamide- and nitrile-oxide-based warheads, may be promising for the development of improved covalent GPX4 inhibitors.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Covalent inhibitors; Ferroptosis; GPX4; Masked electrophiles

Year:  2020        PMID: 32920142      PMCID: PMC8006158          DOI: 10.1016/j.bmcl.2020.127538

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  32 in total

1.  Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis.

Authors:  Kotaro Sakamoto; Satoshi Sogabe; Yusuke Kamada; Shin-Ichi Matsumoto; Akito Kadotani; Jun-Ichi Sakamoto; Akiyoshi Tani
Journal:  Biochem Biophys Res Commun       Date:  2016-11-09       Impact factor: 3.575

2.  FSP1 is a glutathione-independent ferroptosis suppressor.

Authors:  Sebastian Doll; Florencio Porto Freitas; Ron Shah; Maceler Aldrovandi; Milene Costa da Silva; Irina Ingold; Andrea Goya Grocin; Thamara Nishida Xavier da Silva; Elena Panzilius; Christina H Scheel; André Mourão; Katalin Buday; Mami Sato; Jonas Wanninger; Thibaut Vignane; Vaishnavi Mohana; Markus Rehberg; Andrew Flatley; Aloys Schepers; Andreas Kurz; Daniel White; Markus Sauer; Michael Sattler; Edward William Tate; Werner Schmitz; Almut Schulze; Valerie O'Donnell; Bettina Proneth; Grzegorz M Popowicz; Derek A Pratt; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nature       Date:  2019-10-21       Impact factor: 49.962

3.  HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells.

Authors:  Shan Zhu; Qiuhong Zhang; Xiaofan Sun; Herbert J Zeh; Michael T Lotze; Rui Kang; Daolin Tang
Journal:  Cancer Res       Date:  2017-01-27       Impact factor: 12.701

4.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.

Authors:  Valerian E Kagan; Gaowei Mao; Feng Qu; Jose Pedro Friedmann Angeli; Sebastian Doll; Claudette St Croix; Haider Hussain Dar; Bing Liu; Vladimir A Tyurin; Vladimir B Ritov; Alexandr A Kapralov; Andrew A Amoscato; Jianfei Jiang; Tamil Anthonymuthu; Dariush Mohammadyani; Qin Yang; Bettina Proneth; Judith Klein-Seetharaman; Simon Watkins; Ivet Bahar; Joel Greenberger; Rama K Mallampalli; Brent R Stockwell; Yulia Y Tyurina; Marcus Conrad; Hülya Bayır
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

5.  The catalytic site of glutathione peroxidases.

Authors:  Silvio C E Tosatto; Valentina Bosello; Federico Fogolari; Pierluigi Mauri; Antonella Roveri; Stefano Toppo; Leopold Flohé; Fulvio Ursini; Matilde Maiorino
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

6.  Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.

Authors:  Vasanthi S Viswanathan; Matthew J Ryan; Harshil D Dhruv; Shubhroz Gill; Ossia M Eichhoff; Brinton Seashore-Ludlow; Samuel D Kaffenberger; John K Eaton; Kenichi Shimada; Andrew J Aguirre; Srinivas R Viswanathan; Shrikanta Chattopadhyay; Pablo Tamayo; Wan Seok Yang; Matthew G Rees; Sixun Chen; Zarko V Boskovic; Sarah Javaid; Cherrie Huang; Xiaoyun Wu; Yuen-Yi Tseng; Elisabeth M Roider; Dong Gao; James M Cleary; Brian M Wolpin; Jill P Mesirov; Daniel A Haber; Jeffrey A Engelman; Jesse S Boehm; Joanne D Kotz; Cindy S Hon; Yu Chen; William C Hahn; Mitchell P Levesque; John G Doench; Michael E Berens; Alykhan F Shamji; Paul A Clemons; Brent R Stockwell; Stuart L Schreiber
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

7.  Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.

Authors:  Jennifer Tsoi; Lidia Robert; Kim Paraiso; Carlos Galvan; Katherine M Sheu; Johnson Lay; Deborah J L Wong; Mohammad Atefi; Roksana Shirazi; Xiaoyan Wang; Daniel Braas; Catherine S Grasso; Nicolaos Palaskas; Antoni Ribas; Thomas G Graeber
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 38.585

8.  Prolonged and tunable residence time using reversible covalent kinase inhibitors.

Authors:  J Michael Bradshaw; Jesse M McFarland; Ville O Paavilainen; Angelina Bisconte; Danny Tam; Vernon T Phan; Sergei Romanov; David Finkle; Jin Shu; Vaishali Patel; Tony Ton; Xiaoyan Li; David G Loughhead; Philip A Nunn; Dane E Karr; Mary E Gerritsen; Jens Oliver Funk; Timothy D Owens; Erik Verner; Ken A Brameld; Ronald J Hill; David M Goldstein; Jack Taunton
Journal:  Nat Chem Biol       Date:  2015-05-25       Impact factor: 15.040

9.  On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death.

Authors:  Omkar Zilka; Ron Shah; Bo Li; José Pedro Friedmann Angeli; Markus Griesser; Marcus Conrad; Derek A Pratt
Journal:  ACS Cent Sci       Date:  2017-03-07       Impact factor: 14.553

10.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

View more
  4 in total

1.  The AMPK-related kinase NUAK2 suppresses glutathione peroxidase 4 expression and promotes ferroptotic cell death in breast cancer cells.

Authors:  Tanu Singh; Alexander Beatty; Jeffrey R Peterson
Journal:  Cell Death Discov       Date:  2022-05-06

Review 2.  Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.

Authors:  Cadiele Oliana Reichert; Fábio Alessandro de Freitas; Juliana Sampaio-Silva; Leonardo Rokita-Rosa; Priscila de Lima Barros; Debora Levy; Sérgio Paulo Bydlowski
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 3.  Triterpenoids as Reactive Oxygen Species Modulators of Cell Fate.

Authors:  Taotao Ling; Lucinda Boyd; Fatima Rivas
Journal:  Chem Res Toxicol       Date:  2022-03-21       Impact factor: 3.973

Review 4.  The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends?

Authors:  Shuzheng Tan; Ying Kong; Yongtong Xian; Pengbo Gao; Yue Xu; Chuzhong Wei; Peixu Lin; Weilong Ye; Zesong Li; Xiao Zhu
Journal:  Front Mol Biosci       Date:  2022-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.